BioMarin Pharmaceutical Inc. buy Sanford C. Bernstein
Start price
20.08.24
/
50%
€85.64
Target price
20.08.25
€99.09
Performance (%)
-42.16%
End price
21.08.25
€49.53
Summary
This prediction ended on 21.08.25 with a price of €49.53. Massive losses of -42.16% were the result for the BUY prediction by Sanford_C__Bernstein. Sanford_C__Bernstein has a follow-up prediction for BioMarin Pharmaceutical Inc. where he still thinks BioMarin Pharmaceutical Inc. is a Buy. Sanford_C__Bernstein has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioMarin Pharmaceutical Inc. | -2.276% | -2.276% | -17.417% |
| iShares Core DAX® | -0,37 % | 8,40 % | 6,76 % |
| iShares Nasdaq 100 | 2,27 % | 15,23 % | 36,18 % |
| iShares Nikkei 225® | 1,43 % | 14,42 % | 43,11 % |
| iShares S&P 500 | 1,22 % | 10,49 % | 27,28 % |
Comments by Sanford_C__Bernstein for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) was upgraded by analysts at Sanford C. Bernstein from a "market perform" rating to an "outperform" rating. They now have a $110.00 price target on the stock, up previously from $94.00.
Ratings data for BMRN provided by MarketBeat
In the thread Trading BioMarin Pharmaceutical Inc.
Die von Sanford_C__Bernstein gewählte maximale Laufzeit wurde überschritten
Current prediction by Sanford_C__Bernstein for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€52.42
25.02.26
25.02.26
€79.75
25.02.27
25.02.27
-12.76%
16:43
16:43
Stopped prediction by Sanford_C__Bernstein for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€62.80
17.09.24
17.09.24
€80.87
17.09.25
17.09.25
-26.54%
18.09.25
18.09.25